All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
NURIX THERAPEUTICS, INC. Last Reported: 5/31/2024 Stock Symbol: NRIX

Business Address

1700 OWENS STREET, SUITE 205

SAN FRANCISCO , CA US 94158

Mailing Address

1700 OWENS STREET, SUITE 205

SAN FRANCISCO , CA US 94158
Phone Number: (415) 660-5320 / State Incorporated: DE / Fiscal Year End 11 /30

Balance Sheet

Date 2/29/2024 8/31/2023 5/31/2023 2/28/2023 11/30/2021 8/31/2021 5/31/2021 2/28/2021 11/30/2020 8/31/2020 5/31/2020 2/29/2020 11/30/2019 8/31/2019 5/31/2019 2/28/2019 11/30/2018
Cash and Cash Equivalents $49,813,000.00 $42,304,000.00 $58,958,000.00 $33,571,000.00 $80,506,000.00 $147,440,000.00 $188,207,000.00 $126,381,000.00 $119,356,000.00 $265,527,000.00 -- -- $34,816,000.00 $51,849,000.00 -- -- $25,591,000.00
Accounts Receivable Net Current -- $2,000,000.00 -- -- -- -- $2,537,000.00 -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $6,976,000.00 $7,097,000.00 $8,837,000.00 $11,183,000.00 $9,194,000.00 $9,343,000.00 $4,581,000.00 $3,714,000.00 $5,940,000.00 $5,990,000.00 -- -- $1,634,000.00 -- -- -- --
Total Current Assets $250,969,000.00 $267,949,000.00 $290,014,000.00 $288,329,000.00 $311,118,000.00 $358,445,000.00 $396,281,000.00 $310,768,000.00 $298,434,000.00 $364,089,000.00 -- -- $39,354,000.00 -- -- -- --
Property Plant and Equipement $17,871,000.00 $16,581,000.00 $18,495,000.00 $17,717,000.00 $11,340,000.00 $9,569,000.00 $8,345,000.00 $6,960,000.00 $6,672,000.00 $6,532,000.00 -- -- $3,871,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $3,342,000.00 $3,855,000.00 $3,810,000.00 $3,841,000.00 $2,833,000.00 $3,294,000.00 $2,745,000.00 $1,571,000.00 $177,000.00 $185,000.00 -- -- $147,000.00 -- -- -- --
Total Assets $312,674,000.00 $308,195,000.00 $350,624,000.00 $370,154,000.00 $476,771,000.00 $493,074,000.00 $517,981,000.00 $396,660,000.00 $396,343,000.00 $411,874,000.00 -- -- $44,048,000.00 -- -- -- --
Accounts Payable $5,918,000.00 $2,187,000.00 $4,525,000.00 $5,629,000.00 $6,650,000.00 $3,861,000.00 $5,405,000.00 $4,388,000.00 $3,412,000.00 $3,611,000.00 -- -- $1,598,000.00 -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $143,926,000.00 $74,378,000.00 $90,703,000.00 $96,102,000.00 $134,469,000.00 $117,857,000.00 $119,803,000.00 $126,527,000.00 $106,074,000.00 $104,254,000.00 -- -- $53,567,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $755,767,000.00 $738,240,000.00 $728,038,000.00 $719,237,000.00 $563,757,000.00 $558,421,000.00 $552,459,000.00 $398,018,000.00 $393,841,000.00 $391,227,000.00 -- -- $2,740,000.00 -- -- -- --
Accumulated Other Comprehensive Loss $-350,000.00 $-1,228,000.00 $-1,903,000.00 $-3,247,000.00 $-608,000.00 $-59,000.00 $30,000.00 $49,000.00 $87,000.00 $138,000.00 -- -- $-2,000.00 -- -- -- --
Accumulated Deficit $-586,700,000.00 $-503,200,000.00 $-466,300,000.00 $-442,000,000.00 $-220,892,000.00 $-183,190,000.00 $-154,355,000.00 $-127,973,000.00 $-103,698,000.00 $-83,784,000.00 -- -- $-60,456,000.00 -- -- -- --
Total Stockholders' Equity $168,748,000.00 $233,817,000.00 $259,921,000.00 $274,052,000.00 $342,302,000.00 $375,217,000.00 $398,178,000.00 $270,133,000.00 $290,269,000.00 $307,620,000.00 $-61,526,000.00 $-69,802,000.00 $-57,714,000.00 $-44,440,000.00 $-42,197,000.00 $-39,364,000.00 $-36,847,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $312,674,000.00 $308,195,000.00 $350,624,000.00 $370,154,000.00 $476,771,000.00 $493,074,000.00 $517,981,000.00 $396,660,000.00 $396,343,000.00 $411,874,000.00 -- -- $44,048,000.00 -- -- -- --

Statement of Operations

Date 2/29/2024 8/31/2023 5/31/2023 2/28/2023 11/30/2021 8/31/2021 5/31/2021 2/28/2021 11/30/2020 8/31/2020 5/31/2020 2/29/2020 11/30/2019 8/31/2019 5/31/2019 2/28/2019 11/30/2018
Total Revenues $16,585,000.00 $61,828,000.00 $43,361,000.00 $12,685,000.00 $29,750,000.00 $22,354,000.00 $12,102,000.00 $5,011,000.00 $17,820,000.00 $4,085,000.00 $4,182,000.00 $2,864,000.00 $31,115,000.00 $10,580,000.00 $9,439,000.00 $9,234,000.00 --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $50,005,000.00 $139,435,000.00 $91,579,000.00 $45,816,000.00 $116,434,000.00 $30,906,000.00 $48,997,000.00 $23,003,000.00 $66,494,000.00 $46,049,000.00 -- $12,967,000.00 $45,025,000.00 $32,201,000.00 -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $61,804,000.00 $171,557,000.00 $113,078,000.00 $55,637,000.00 $147,636,000.00 $102,287,000.00 $63,038,000.00 $29,533,000.00 $82,803,000.00 $56,106,000.00 -- $15,417,000.00 $53,351,000.00 $37,925,000.00 -- -- --
Loss from Operations $-45,219,000.00 $-109,729,000.00 $-69,717,000.00 $-42,952,000.00 $-117,886,000.00 $-28,997,000.00 $-50,936,000.00 $-24,522,000.00 $-64,983,000.00 $-44,975,000.00 -- $-12,553,000.00 $-22,236,000.00 $-8,672,000.00 -- -- --
Loss Before Income Taxes $-41,428,000.00 -- -- -- $-117,063,000.00 $-28,958,000.00 $-50,447,000.00 $-24,204,000.00 $-63,777,000.00 $-43,904,000.00 -- $-12,380,000.00 $-21,460,000.00 $-8,151,000.00 -- -- --
Earnings Per Share Basic $-0.76 $-1.88 $-1.20 $-0.75 -- -- $-1.23 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 54,903,407 54,227,491 54,144,909 54,028,238 -- -- 41,318,281 -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.76 $-1.88 $-1.20 $-0.75 -- -- $-1.23 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 54,903,407 54,227,491 54,144,909 54,028,238 -- -- 41,318,281 -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 -- -- 65,000,000 -- -- -- --
Common Stock Shares Outstanding 49,136,954 48,503,768 47,631,208 47,444,853 44,664,371 44,556,604 44,403,547 39,119,315 38,864,872 38,845,196 -- -- 3,595,334 -- -- -- --
Common Stock Value $49,000.00 $49,000.00 $48,000.00 $47,000.00 $45,000.00 $45,000.00 $44,000.00 $39,000.00 $39,000.00 $39,000.00 -- -- $4,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com